Determination of tetracyclines in human urine samples by capillary electrophoresis in combination with field amplified sample injection

A sensitive method using CZE‐UV detection has been developed for the determination of five tetracycline antibiotics in human urine samples. To improve the sensitivity of the method, an on‐line preconcentration strategy, named field‐amplified sample injection, has been developed, based on the electrokinetic injection of the sample, which requires only a 1:100 dilution with sample solvent before injection. Under optimum conditions, sensitivity enhancement factors ranged from 450 to 800 for the studied compounds. The applicability of the proposed method was demonstrated by the determination of these antibiotics in spiked urine samples. The limits of quantification were lower than 0.8 mg/L and the precision (intra‐ and inter‐day), expressed as %RSD was below 14%. Recoveries ranged from 92.1 to 96.7%. Thus, the proposed procedure is a simple, fast and efficient strategy which could be used as therapeutic drug monitoring in human urine samples.     

Digoxin and metabolites in urine and feces: a fluorescence derivatization--high-performance liquid chromatographic technique

A high-performance liquid chromatography method is described for the determination of digoxin and its metabolites digoxigenin, digoxigenin monodigitoxoside, digoxigenin bis-digitoxoside and dihydrodigoxin (20S and 20R) excreted in urine and feces. The urine sample or fecal supernatant is extracted with methylene chloride in the presence of digitoxigenin or digitoxin as internal standard. Pre-column derivatization is achieved using 1-naphthoyl chloride with subsequent separation of the derivatized compounds on either a normal- or reversed-phase system with fluorescence detection. Recoveries for digoxin and all metabolites from fecal samples were in the range 60-74%, which is comparable to that previously determined for urine samples. Standard curve data revealed linearity over a wide range of concentrations. Coefficients of variation for the analysis were less than 10% for all compounds over a range of 5-125 ng per ml urine and 10-250 ng per 200 mg feces. Peaks for digoxin and metabolites in urine and feces were obtained when human excreta were analyzed.     

Determination of Gentian Violet in human urine and poultry feed by high performance liquid chromatography with electrochemical detection using a carbon fibre microelectrode flow cell

A sensitive and relatively selective high performance liquid chromatographic method for the determination of Gentian Violet (GV) in human urine and chicken feed is described. The method is based on solid-phase extraction, with subsequent reversed-phase chromatographic separation on a cyano column and amperometric detection using a carbon fibre microelectrode flow cell operated at + 1.3 V. The peak currents were directly proportional to GV concentration over the concentration range 1-30 ppb (for urine samples analysis) and 1-20 ppm for poultry feed analysis. Using this method, the minimum detectable concentration was estimated to be 0.5 ppb. The method was applied successfully to the determination of GV in human urine and in chicken feed, and it was concluded that the method could be applied to the quantitative analysis of GV in the presence of its major metabolite, leuco GV. In the proposed procedure, the occurrence of matrix effects during urine analysis was significant. The electrochemical pretreatment regime described in this paper was used to overcome these effects. Recovery studies were performed on both the human urine and chicken feed samples. The recovery of GV ranged from 92 to 96% in both matrices, with a relative standard deviation of less than 5.5%.     

Simultaneous determination of cadmium and lead in urine by means of computerized potentiometric stripping analysis

In computerized potentiometric stripping analysis for cadmium and lead in urine the samples are acidified with hydrochloric acid to a total concentration equal to 0.5 M. The sample is pre-electrolyzed at —1.25 V vs. SCE for 2 min without prior sample heating or deoxygenation, the working electrode being a mercury pre-coated glassy-carbon electrode. The lead and cadmium concentrations are evaluated by means of standard addition. Detection limits are 1 nM for both elements. Results obtained by potentiometric stripping analysis and by solvent extraction/atomic absorption are compared for samples from unexposed persons and from one patient under penicillamine treatment. The relative merits of the potentiometric stripping, anodic stripping and atomic absorption techniques are discussed.     

Determination of cadmium and lead in urine and other biological samples by graphite-furnace atomic-absorption spectrometry

A method for determining cadmium and lead in urine and other biological samples by graphite-furnace atomic-absorption spectrometry is reported. Samples were analysed after wet or dry ashing and without extraction or matrix-modification techniques, in laminar-flow clean-room; negligible blank contributions were found. Matrix interference effects were observed only for lead and were resolved by the method of standard additions. Five NBS biological reference materials were used as internal quality-control standards. The urinary levels for non-exposed volunteers ranged from 0.16 +/- 0.01 to 1.65 +/- 0.20 and from 6 +/- 1 to 31 +/- 6 ng/ml for cadmium and lead, respectively; this corresponds to 0.15 +/- 0.02 to 2.01 +/- 0.16 and 7 +/- 1 to 31 +/- 3 mug/day. The average relative standard deviation for 60 urine samples was 10% for cadmium and 13% for lead.     

A new flow injection preconcentration method based on multiwalled carbon nanotubes for the ETA-AAS determination of Cd in urine

A new flow injection (FIA) procedure for the preconcentration of cadmium in urine using multiwalled carbon nanotubes (MWCNT) as sorbent and posterior electrothermal atomization atomic absorption spectrometry (ETA-AAS) Cd determination has been developed. Cadmium was retained in a column filled with previously oxidized MWCNTs and it was quantitatively eluted with a nitric acid solution. The parameters influencing the adsorption-elution process such as pH of the sample solution, amount of sorbent and flow rates of sample as well as eluent solutions have been studied. Cd concentration in the eluent was measured by ETA-AAS under the optimized conditions obtained. The results indicated the elimination of urine matrix effect as a consequence of the preconcentration process performed. Total recovery of cadmium from urine at pH 7.2 using a column with 45 mg of MWCNTs as sorbent and employing a HNO₃ 0.5 mol L⁻¹ solution for elution was attained. The detection limit obtained was 0.010 μg L⁻¹ and the preconcentration factor achieved was 3.4. The method showed adequate precision (RSD: 3.4-9.8%) and accuracy (mean recovery: 97.4-100%). The developed method was applied for the determination of cadmium in real urine samples from healthy people (in the range of 0.14-2.94 μg L⁻¹) with satisfactory results.     

Determination of ethyl sulfate--a marker for recent ethanol consumption--in human urine by CE with indirect UV detection

A CE method for the determination of the ethanol consumption marker ethyl sulfate (EtS) in human urine was developed. Analysis was performed in negative polarity mode with a background electrolyte composed of 15 mM maleic acid, 1 mM phthalic acid, and 0.05 mM cetyltrimethylammonium bromide (CTAB) at pH 2.5 and indirect UV detection at 220 nm (300 nm reference wavelength). This buffer system provided selective separation conditions for EtS and vinylsulfonic acid, employed as internal standard, from urine matrix components. Sample pretreatment of urine was minimized to a 1:5 dilution with water. The optimized CE method was validated in the range of 5-700 mg/L using seven lots of urine. Intra- and inter-day precision and accuracy values, determined at 5, 60, and 700 mg/L with each lot of urine, fulfilled the requirements according to common guidelines for bioanalytical method validation. The application to forensic urine samples collected at autopsies as well as a successful cross-validation with a LC-MS/MS-based method confirmed the overall validity and real-world suitability of the developed expeditious CE assay (sample throughput 130 per day).     

Kinetic fluorimetric study of the oxidation reaction of folinic acid (leucovorin) with potassium permanganate. Determination in human urine

In this study a kinetic fluorimetric method for the determination of folinic acid (leucovorin, LV) in human urine has been developed. The fluorescence emission generated by the oxidation reaction between LV and potassium permanganate in alkaline medium has been monitored at 360nm (excitation wavelength 290nm). The effect of instrumental and experimental variables on the reaction was investigated and a 0.17M sodium hydroxide, 3.3x10(-5)M KMnO(4) concentration and a temperature of 70 degrees C were selected for the reaction. The concentration range has been optimized between 10 and 700ngml(-1) of LV. The correlation coefficient was 0.9989. The sensitivity of the proposed method is 9.5ngml(-1) (expressed as limit of detection in accordance with the Clayton criterion). The determination time per sample is smaller than 200s. The proposed kinetic fluorimetric method has been applied to the direct determination of this compound in human urine. Recovery values from urine samples, containing LV, range from 82 to 110% (mean 96%).     

Microwave digestion and matrix separation for the determination of cadmium in urine samples by electrothermal atomization atomic absorption spectrometry using a fast temperature program

 A method is proposed which involves sample pretreatment followed by electrothermal atomic absorption spectrometry (ETAAS) for determination of cadmium in human urine. A microwave digestion system was devised to accommodate double-closed vessels for simultaneous digestion of batches of up to 24 urine samples in about 20 min. After digestion, matrix substances which might interfere were removed using silica-immobilized 8-hydroxyquinoline (I-8HOQ) columns. The analyte adsorbed on the column was then eluted with dilute nitric acid solution and determined by ETAAS using a fast temperature program. Neither ashing steps in the furnace heating program nor use of matrix modifiers was necessary. The accuracy, precision, limit of detection, and sample throughput of the method were evaluated. With meticulous control of systematic errors which may be introduced in the pretreatment procedures, the present method can serve as a reference technique for the analysis of Cd in urine samples. Received: 29 July 1996/Revised: 30 September 1996/Accepted: 13 October 1996     

Microwave digestion and matrix separation for the determination of cadmium in urine samples by electrothermal atomization atomic absorption spectrometry using a fast temperature program

 A method is proposed which involves sample pretreatment followed by electrothermal atomic absorption spectrometry (ETAAS) for determination of cadmium in human urine. A microwave digestion system was devised to accommodate double-closed vessels for simultaneous digestion of batches of up to 24 urine samples in about 20 min. After digestion, matrix substances which might interfere were removed using silica-immobilized 8-hydroxyquinoline (I-8HOQ) columns. The analyte adsorbed on the column was then eluted with dilute nitric acid solution and determined by ETAAS using a fast temperature program. Neither ashing steps in the furnace heating program nor use of matrix modifiers was necessary. The accuracy, precision, limit of detection, and sample throughput of the method were evaluated. With meticulous control of systematic errors which may be introduced in the pretreatment procedures, the present method can serve as a reference technique for the analysis of Cd in urine samples. Received: 29 July 1996/Revised: 30 September 1996/Accepted: 13 October 1996     

Selective Determination of Verapamil in Pharmaceutics and Urine Using a Boron‐doped Diamond Electrode Coupled to Flow Injection Analysis with Multiple‐pulse Amperometric Detection

This work presents a simple and low‐cost method for fast and selective determination of Verapamil (VP) in tablets and human urine samples using a boron‐doped diamond working electrode (BDD) coupled to a flow injection analysis system with multiple pulse amperometric detection (FIA‐MPA). The electrochemical behaviour of VP in 0.1 mol L⁻¹ sulfuric acid showed three merged oxidation peaks at around +1.4 V and upon reverse scan, one reduction peak at 0.0 V (vs. Ag/AgCl). The MPA detection was performed applying a sequence of three potential pulses on BDD electrode: (1) at +1.6 V for VP oxidation, (2) at +0.2 V for reduction of the oxidized product and (3) at +0.1 V for cleaning of the working electrode surface. The FIA system was optimized with injection volume of 150 μL and flow rate of 3.5 mL min⁻¹. The method showed a linear range from 0.8 to 40.0 μmol L⁻¹ (R>0.99) with a low limit of detection of 0.16 μmol L⁻¹, good repeatability (RSD<2.2 %; n=10) and sample throughput (45 h⁻¹). Selective determination of VP in urine was performed at+0.2 V due to absence of interference from ascorbic and uric acids in this potential. The addition‐recovery tests in both samples were close to 100 % and the results were similar to an official method.     

Determination of beryllium and selenium in human urine and of selenium in human serum by graphite-furnace atomic absorption spectrophotometry.

For human urine beryllium (Be), each sample (500 microl) was diluted (1+1) with Nash reagent (containing 0.2% (v/v) acetylacetone and 2.0 M ammonium acetate buffer at pH 6.0) and then a 20-microl volume of Triton X-100 (0.4%, v/v) aqueous solution was added. An aliquot (10 microl) of the diluted urine mixture was introduced into a graphite cuvette and was atomized according to a temperature program. The method detection limit (MDL, 3sigma) for Be was 0.37 microg/l in the undiluted urine sample and the calibration graph was linear up to 65.0 microg/l. Calibration graphs were prepared by the standard addition method. Accuracies of 98.6-102% were obtained when testing standard reference material (SRM 2670) freeze dried human urine samples. Precision (relative standard deviation, RSD) for urine Be was < or = 2.3% (withinrun, n = 5) and was < or = 3.0% (between-run, n = 3). For human urine and serum selenium (Se), samples (100 microl) were diluted with HNO3 (0.2%, v/v) to make a (1+1) dilution for urine analysis or a (1+4) dilution for serum analysis. An additional aliquot (10 microl) of Triton X-100 (0.1%, v/v) was added to each 200 microl of (1+1) diluted urine (or 20 microl of the Triton X-100 was added to each 500 microl of (1+4) diluted serum) sample. After the diluted sample mixture (10 microl) was introduced into a graphite cuvette, the corresponding chemical modifier (10 microl, containing Ni2+ + Pd + NH4NO3 in HNO3 (0.2%, v/v)) was added to it and the mixture was atomized. The MDL (3sigma) for Se in urine and in serum was 4.4 and 21.4 microg/l in undiluted sample, respectively, and the calibration graphs were linear up to 150 and 400 microg/l. Accuracies of urine Se were 98.9 - 99.4% by testing SRM 2670 (NIST) urine standards with RSD (between-run, n = 3) within 2.9%; and that of serum Se was 97.2% when testing a certified second-generation human serum (No. 29, #664) with RSD (between-run, n = 3) of 1.4%. The proposed method can be applied easily, directly, and accurately to the measurement of Be and Se in real samples (including six urine Se and four serum Se from patients of Blackfoot Disease in Taiwan).     

Microanalyzer for biomonitoring lead (Pb) in blood and urine

Biomonitoring of lead (Pb) in blood and urine enables quantitative evaluation of human occupational and environmental exposures to Pb. State-of-the-art ICP–MS instruments can only analyze metals in laboratories, resulting in lengthy turnaround times, and they are expensive. In response to the growing need for a metal analyzer capable of on-site, real-time monitoring of trace toxic metals in individuals, we developed a portable microanalyzer based on flow-injection/stripping voltammetry (ASV), and validated the system using rat blood and urine spiked with known amounts of Pb. Fouling of electrodes by proteins often prevents the effective use of electrochemical sensors in biological matrices. Minimization of such fouling was accomplished with suitable sample pretreatment and by establishing turbulent flow of blood and urine containing Pb onto the electrode inside the microanalyzer, which resulted in no apparent electrode fouling even when the samples contained 50% urine or 10% blood by volume. No matrix effect was observed for the voltammetric Pb signals, even when the samples contained 10% blood or 10% urine. The microanalyzer offered linear concentration ranges relevant to Pb exposure levels in humans (0–20 ppb in 10% blood samples, 0–50 ppb in 50% urine samples). The device showed excellent sensitivity and reproducibility; Pb detection limits were 0.44 ppb and 0.46 ppb, and % R.S.D. was 4.9 and 2.4 in 50% urine and 10% blood samples, respectively. It gave similar Pb concentrations in blood and urine to those measured by ICP–MS. It offered high throughput (3 min per sample) and economical use of samples (60 μL per measurement) as well as low reagent consumption (1 μg of Hg per measurement), thus minimizing environmental concerns associated with mercury use. Since it is miniaturized, the microanalyzer is portable and field-deployable. Thus, it shows much promise as the next-generation analyzer for the biomonitoring of toxic metals.     

Determination of S-phenylmercapturic acid in human urine using an automated sample extraction and fast liquid chromatography-tandem mass spectrometric method

S-phenylmercapturic acid is widely accepted as a specific biomarker for the evaluation of benzene exposure. Here, we describe a fast, specific and sensitive high-performance liquid achromatography coupled with tandem mass spectrometry (LC-MS/MS) method that has been developed and validated for the determination of S-phenylmercapturic acid in human urine. Isotope-labeled S-phenylmercapturic acid-d5 was used as internal standard to improve the method ruggedness. The fully automated solid-phase extraction method on a 96-well Oasis MAX (mix-mode anion exchange) plate was employed to clean up the urine samples before analysis. The rapid LC-MS/MS analysis of extracted samples was achieved on a Genesis C18 column with a run time of only 3 min. Negative electrospray ionization with multiple reaction monitoring (ESI-MRM) mode was used to detect S-phenylmercapturic acid (m/z 238 --> 109) and S-phenylmercapturic acid -d5 (m/z 243 --> 114). The method fulfils all the standard requirements of method validation. The calibration curve was linear within the concentration range 0.400-200 ng/mL. The method performed accurately and precisely in validation with <7.5% relative error and <6.5% relative standard deviation of quality control samples. The method efficacy was also verified by the analysis of urine samples from 12 smokers and 12 non-smokers. With the fully automated sample cleanup procedure and the fast LC-MS/MS analysis, a sample analysis throughput of 384 samples per day could be achieved.     

Direct determination of chlorpyrifos and its main metabolite 3,5, 6-trichloro-2-pyridinol in human serum and urine by coupled-column liquid chromatography/electrospray-tandem mass spectrometry

A rapid and sensitive automated coupled-column liquid chromatography/electrospray tandem mass spectrometry (LC/LC/ES-MS/MS) method has been developed for the quantitation of chlorpyrifos and 3,5,6-trichloro-2-pyridinol (TCP) in both human serum and urine. Human serum was first protein precipitated with acetonitrile, while urine was directly injected into the coupled-column system. A 10 microL aliquot was then analyzed using as first separation column a Discovery C18 5 microm 50 x 2.1 mm; the fraction containing the analyte was transferred on-line to the second column consisting of a ABZ+ 5 microm 100 x 2.1 mm, which was connected to the electrospray source (Z-spray) of a Quattro LC triple-quadrupole instrument. Chlorpyrifos was detected in positive ion mode using four multi reaction monitoring (MRM) transitions while TCP was measured in negative ion mode using three pseudo-MRM transitions. The clean-up performed by the coupled-column approach avoids the use of an internal standard for the correct quantitation of both analytes, and the highly automated procedure renders a sample throughput of more than 100 samples per day. Both compounds can be determined using the same set-up, the only difference in the procedure being the composition of the first mobile phase. The method has proved to be fast, reliable and sensitive, yielding calibration curves for both analytes with correlation coefficients greater than 0.9995. The repeatability and reproducibility at 5 and 50 ng/mL was lower than 8%. The accuracy and precision were evaluated by means of recovery experiments from fortified serum (5-50 ng/mL) and urine (1-10 ng/mL) samples, obtaining satisfactory recoveries for both compounds (87-113% in serum, and 98-109% in urine), with coefficients of variation (CVs) less than 10%. The detection limits were similar for chlorpyrifos and metabolite: 1.5 ng/mL in serum, and 0.5 ng/mL in urine, where no sample handling took place. The validated procedures provide excellent tools for the specific assessment of occupational exposure to the organophosphorus pesticide chlorpyrifos, throughout the analysis of both human serum and urine, and it is more selective and sensitive than the current assay based on the measurement of the decrease in the cholinesterase activity.     

Direct determination of lead in human blood and selenium, cadmium, copper, zinc in serum by electrothermal atomic absorption spectrophotometry using Zeeman effect background correction

Summary The procedure for the direct determination of lead in human blood and selenium, cadmium, copper and zinc from human blood serum with micro quantities of the samples are described using electrothermal atomic absorption spectrophotometry with L'vov platform and Zeeman correction. No predigestion or extraction procedures are required. The analyses are performed by simple dilution of the specimen with Triton X-100 and/or proper matrix modifier. The method of standard additions and peak area measurement are used for quantitation. L'vov platforms have been used for all elements except cooper. Use of micro quantity of the sample, better reproducibility, low detection limit and possibility of analyzing a large number of samples per day made this technique particularly suitable as routine analytical procedure in clinical laboratory. The procedures for determination of the metal ions are applied on sixty normal persons and twenty-two cardiomyopathy patients to find any correlation.     

A study of differential potentiometric stripping analysis for lead and cadmium with Nafion coated carbon fibre electrode

The differential potentiometric stripping analysis (DPSA) with Nafion coated carbon fibre electrode has been studied, and a method to determine lead and cadmium in urine directly has been attempted. The effect of various experimental parameters on the DPSA response is discussed. The experimental conditions include 0.2M sodium perchlorate, deposition potential of ?1.0 or ?1.1 V and using 20 ppm mercuric ion as oxidizing agent. The response of the signal is in linear relation with the concentrations of lead and cadmium respectively up to 0.5 ppm. The electrode coated with Nafion film alleviates the interference from organics in urine samples.     

Liquid chromatographic determination of hyoscine (scopolamine) in urine using solid phase extraction.

A sensitive method for the determination of hyoscine (scopolamine) in urine is described. After concentration and "clean-up" on C18 and CN solid phase extraction columns, hyoscine was quantified by high performance liquid chromatography with coulometric detection (oxidation at +0.9 V). The limit of detection was 5 ng per sample and the precision for 5 mL samples containing 2 ng/mL was 12.3%. The method was applied to urine samples collected from 12 volunteers wearing Scopoderm TTS patches. The mean excretion rate of unmetabolized hyoscine was 0.45 micrograms/h and 87% of the total hyoscine was present as conjugates. Apohyoscine (aposcopolamine) was identified as a urinary metabolite. The significance of this with regard to hyoscine assays is discussed.     

Automated high-throughput method using solid-phase microextraction-liquid chromatography-tandem mass spectrometry for the determination of ochratoxin A in human urine

A new automated, high-throughput method for the determination of ochratoxin A (OTA) in human urine samples has been optimized and validated using solid-phase microextraction coupled to liquid chromatography-tandem mass spectrometry (SPME-LC-MS/MS). High-throughput was achieved by simultaneous preparation of up to 96 samples using multi-fiber SPME device and multi-well plates. A carbon-tape coating was chosen for the first time as the best extracting phase for this contaminant. The proposed method required only minimal sample pre-treatment to adjust sample pH to 3.0 using a dilution (1:1) with 0.5M phosphate-buffered saline. A simple gradient guaranteed a good chromatographic separation from matrix interferences in only 8min. Relative recovery (%), precision and linearity validation results met Food and Drug Administration acceptance criteria at three concentration levels (1, 10, and 50ng/mL), indicating excellent performance of the proposed method. Limits of detection and quantitation were 0.3 and 0.7ng/mL in urine, respectively. OTA determination in urine is a good marker for human exposure to this mycotoxin. It is also less invasive than blood analysis. This method is fully automated and the SPME technique is simpler, less time-consuming and cheaper compared with most widely adopted clean-up procedures for OTA extraction from urine.     

Determination of cadmium in water by ICP-AES with on-line adsorption preconcentration using DPTH-gel and TS-gel microcolumns

Two flow injection inductively coupled plasma atomic emission spectrometric methods for the preconcentration and determination of trace amounts of cadmium in sea-water and waste-water samples are described based on the adsorption of the metal ion on a micro-column placed in the injection valve of the FI manifold and packed with silica gel funtionalised with 1,5-bis(di-2-pyridyl) methylene thiocarbohydrazide (DPTH-gel) and silica gel functionalised with methylthiosalicylate (TS-gel), respectively. Various parameters and chemical variables affecting the preconcentration and determination of this metal by ICP-AES are evaluated. The DPTH-gel preconcentration method has a linear calibration range from 5 to at least 100 ng ml(-1) of cadmium, with a R.S.D. of 1.1% for ten independent analyses of 100 ng ml(-1), a detection limit of 1.1 ng ml(-1) and a throughput of 40 samples per hour using a 60 s preconcentration time. The TS-gel preconcentration method shows a linear range between 10 and 100 ng ml(-1), with a R.S.D. of 2.5% for ten independent analyses of 100 ng ml(-1), a detection limit of 4.3 ng ml(-1) and a sample throughput of 24 samples per hour for a preconcentration time of 120 s. Validation was carried out against a certified reference water sample and by determining the analyte content in spiked synthetic sea-water, sea-water and waste-water.